AIM Innovators: Creo Medical initiates partnership strategy

Creo Medical (CREO) is continuing to deliver on the goals set out in its 2016 IPO – just about. It’s true that the surgical endoscopy company might have been a little ambitious with its quest for commercialisation – initiating general sales roll-out by 2019 was always going to be tricky and the group’s first material revenue (£9.4m in the financial year to December 2020) came largely from acquisitions rather than the group’s own product roll-out. Meanwhile the £30m fundraising last year certainly wasn’t on the agenda when the group first came to market. But the product suite remains relevant and…